We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

BMRN boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Shares of BioMarin Pharmaceutical are trading at a forward earnings multiple of 14.3X, as well as a ...

Below is Validea's guru fundamental report for BIOMARIN PHARMACEUTICAL INC (BMRN). Of the 22 guru strategies we follow, BMRN rates highest using our Value Investor model based on the published ...

In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a ...

BMRN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 14.32; value investors ...

In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other most profitable biotech stocks to buy right now. With improved market ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Investment analysts at William Blair dropped their Q1 2025 earnings estimates for shares of BioMarin Pharmaceutical in a report ...